Oncology Institute (TOI) Institutional Ownership → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free TOI Stock Alerts $1.18 -0.02 (-1.67%) (As of 04/25/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Oncology Institute (NASDAQ:TOI)CurrentInstitutional OwnershipPercentage36.86%Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$5.94MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$156.57K Get TOI Insider Trade Alerts Want to know when executives and insiders are buying or selling Oncology Institute stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TOI Institutional Buying and Selling by Quarter Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. Oncology Institute Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/18/2024 Quattro Financial Advisors LLC55,960$88K0.0%N/A0.075% 2/14/2024Kent Lake Capital LLC1,085,171$2.21M0.9%+492.3%1.471% 2/13/2024Tower Research Capital LLC TRC 12,046$25K0.0%N/A0.016% 2/8/2024Cincinnati Insurance Co.699,500$1.43M0.0%N/A0.948% 2/7/2024Josh Arnold Investment Consultant LLC1,856,329$3.79M3.7%-1.1%2.517% 2/6/2024Fielder Capital Group LLC70,192$143K0.1%N/A0.095% Get the Latest News and Ratings for TOI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter. 1/23/2024WealthShield Partners LLC24,126$49K0.0%N/A0.033% 1/1/2024Vanguard Group Inc.1,758,034$2.46M0.0%-0.3%2.384% 11/22/2023Josh Arnold Investment Consultant LLC1,877,472$2.65M2.8%+77.4%2.546% 11/15/2023Kent Lake Capital LLC183,215$257K0.1%N/A0.251% 11/14/2023Saba Capital Management L.P.94,264$132K0.0%-44.7%0.129% 11/8/2023Vanguard Personalized Indexing Management LLC21,269$30K0.0%N/A0.029% 11/8/2023Tiff Advisory Services LLC423,405$593K0.5%N/A0.580% 9/7/2023Triatomic Management LP904,689$498K0.5%+11.7%1.240% 8/14/2023Prosight Management LP455,302$251K0.1%+61.5%0.604% 5/3/2023Triatomic Management LP810,145$549K0.4%+56.6%1.087% 2/16/2023Josh Arnold Investment Consultant LLC104,400$172K0.3%N/A0.140% 2/14/2023Triatomic Management LP517,479$854K0.7%+41.5%0.695% 11/16/2022Saba Capital Management L.P.348,059$1.61M0.0%-5.2%0.475% 11/15/2022Parian Global Management LP240,724$1.12M3.6%+31.0%0.329% 11/8/2022New York State Common Retirement Fund10,974$51K0.0%-30.5%0.015% 10/26/2022 Allspring Global Investments Holdings LLC10,919$50K0.0%N/A0.015% 8/16/2022Parian Global Management LP183,828$930K4.3%-58.6%0.251% 8/16/2022Deerfield Management Company L.P. Series C3,383,099$17.12M0.4%+2.6%4.617% 5/17/2022Empery Asset Management LP70,733$504K2.4%-64.6%0.097% 5/12/2022Triatomic Management LP428,100$3.05M2.5%+7.0%0.584% 5/9/2022Qube Research & Technologies Ltd37,850$270K0.0%+102.5%0.052% 2/15/2022Saba Capital Management L.P.400,000$3.73M0.1%N/A1.391% 2/14/2022Parian Global Management LP466,676$4.55M3.7%N/A1.623% 2/14/2022Redmile Group LLC2,500,000$24.38M0.6%N/A8.696% 2/14/2022Deerfield Management Company L.P. Series C3,296,107$32.14M0.7%N/A11.465% 2/10/2022Qube Research & Technologies Ltd18,688$182K0.0%N/A0.065% (Data available from 1/1/2016 forward) TOI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TOI shares? During the previous two years, 19 institutional investors and hedge funds held shares of Oncology Institute. The most heavily invested institutionals were Deerfield Management Company L.P. Series C ($17.12M), Josh Arnold Investment Consultant LLC ($3.79M), Vanguard Group Inc. ($2.46M), Kent Lake Capital LLC ($2.21M), Cincinnati Insurance Co. ($1.43M), Parian Global Management LP ($1.12M), and Tiff Advisory Services LLC ($593K).Learn more on TOI's institutional investors. What percentage of Oncology Institute stock is owned by institutional investors? 36.86% of Oncology Institute stock is owned by institutional investors. Learn more on TOI's institutional investor holdings. Which institutional investors have been buying Oncology Institute stock? Of the 15 institutional investors that purchased Oncology Institute stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Kent Lake Capital LLC ($1.09M), Josh Arnold Investment Consultant LLC ($923.72K), Cincinnati Insurance Co. ($699.50K), Triatomic Management LP ($567.11K), Tiff Advisory Services LLC ($423.41K), Prosight Management LP ($173.40K), and Deerfield Management Company L.P. Series C ($86.99K). How much institutional buying is happening at Oncology Institute? Institutional investors have bought a total of 4,229,869 shares in the last 24 months. This purchase volume represents approximately $7.46M in transactions. Which Oncology Institute major shareholders have been selling company stock? The following institutional investors have sold Oncology Institute stock in the last 24 months: Parian Global Management LP ($260.42K), Empery Asset Management LP ($129.27K), Saba Capital Management L.P. ($95.35K), Josh Arnold Investment Consultant LLC ($21.14K), Vanguard Group Inc. ($4.92K), and New York State Common Retirement Fund ($4.83K). How much institutional selling is happening at Oncology Institute? Institutional investors have sold a total of 515,915 shares in the last 24 months. This volume of shares sold represents approximately $2.51M in transactions. Related Companies: SHL Telemedicine Major Shareholders Pono Capital Two Major Shareholders Clearside Biomedical Major Shareholders Aclaris Therapeutics Major Shareholders ARYA Sciences Acquisition Corp IV Major Shareholders BrainsWay Major Shareholders AlloVir Major Shareholders Protalix BioTherapeutics Major Shareholders 111 Major Shareholders Precision BioSciences Major Shareholders This page (NASDAQ:TOI) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.